Prediction of breast cancer risk based on profiling with common genetic variants

scientific article published on 8 April 2015

Prediction of breast cancer risk based on profiling with common genetic variants is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/JNCI/DJV036
P932PMC publication ID4754625
P698PubMed publication ID25855707
P5875ResearchGate publication ID277325579

P50authorElza KhusnutdinovaQ4502509
Alan AshworthQ4706084
Julian PetoQ6307461
Jan LubińskiQ11718282
Anne-Lise Børresen-DaleQ11958220
Nazneen RahmanQ16734865
Georgia Chenevix-TrenchQ17517031
Christine L. ClarkeQ56204859
Mikael ErikssonQ56528259
Siranoush ManoukianQ56697298
Anja RudolphQ56722646
John HopperQ56726496
Yon-Dschun KoQ114292610
Mitul ShahQ114292631
Craig LuccariniQ114292632
Helen TsimiklisQ114292641
Mervi GripQ114292643
Senno VerhoefQ114292649
Hatef DarabiQ114292651
Robert A E M TollenaarQ114292652
Ursula EilberQ114292658
Melanie J MaranianQ114292661
Hans-Ulrich UlmerQ114337476
Darya ProkofyevaQ114337497
Rohini Rau-MurthyQ114337499
Primitiva MenéndezQ114337513
Petra SeiboldQ114337534
Linetta B KoppertQ114337603
Erik van LimbergenQ114337620
Ruth SwannQ114337660
Nicola MillerQ115136498
Guillermo PitaQ115136499
Michael BremerQ115727182
Zalina TakhirovaQ125345801
Roger L. MilneQ56855807
Javier BenitezQ56856067
Nasim MavaddatQ56875622
Joe DennisQ56875626
Vijai JosephQ56875726
Volker ArndtQ57305816
Sajjad RafiqQ57320710
Mark N BrookQ57517906
Jose Ignacio Arias PerezQ57518122
Silje H. NordgardQ57973108
Christi J van AsperenQ58235238
Anna JakubowskaQ58323317
Louise A. BrintonQ58623846
Anna Marie MulliganQ59659727
Anna González-NeiraQ30003814
Simon S. CrossQ30505778
Alison DunningQ30506457
Robert N. LubenQ30506463
Graham GilesQ30524411
Montserrat García-ClosasQ28356305
Loic Le MarchandQ28360612
Kamila CzeneQ28484009
Angela CoxQ28484012
Hiltrud BrauchQ28484013
Barbara BurwinkelQ28484015
Ute HamannQ28484017
Jolanta LissowskaQ28606996
Hermann BrennerQ28958315
Kristiina AittomäkiQ29840622
Heli NevanlinnaQ29840669
Esther M. JohnQ59752419
Sune G. NielsenQ59763235
Douglas F. EastonQ59812154
Anthony SwerdlowQ60492223
Leslie BernsteinQ60607806
Frank DudbridgeQ60878633
Diana EcclesQ61756107
Paul D P PharoahQ61822938
Per HallQ62593354
Alfons MeindlQ63015490
Fergus J. CouchQ63018779
Susan L NeuhausenQ63019538
Ian TomlinsonQ63213090
Asta FörstiQ63213696
Peter A. FaschingQ64005064
Fredrick SchumacherQ64183024
Arif B. EkiciQ64409983
Annika LindblomQ64516098
Jacques SimardQ64516110
Irene L AndrulisQ64516140
Wei ZhengQ67482021
Clare TurnbullQ67482869
Catriona A. McLeanQ68267862
Jianjun LiuQ68692572
Jonine FigueroaQ71778357
Sara MargolinQ72940025
Matthias W. BeckmannQ72940290
Stig Egil BojesenQ72992763
Christopher A. HaimanQ73606228
Kenneth OffitQ20732365
David J. HunterQ21066148
Jenny Chang-ClaudeQ21263057
Rita SchmutzlerQ21264574
Diether LambrechtsQ26923514
Stephen ChanockQ27662321
Hoda Anton-CulverQ28052887
Veli-Matti KosmaQ37068464
Katarzyna DurdaQ37068937
Vesa KatajaQ37069167
Arja Jukkola-VuorinenQ37069253
Arto MannermaaQ37070123
Pascal GuénelQ37070260
Kyriaki MichailidouQ37070465
Dieter Flesch-JanysQ37071144
Katri PylkäsQ37071955
Thérèse TruongQ37072552
Drakoulis YannoukakosQ37073411
Robert WinqvistQ37074224
Antoinette HollestelleQ37074515
Andreas SchneeweissQ37074948
Aida Karina DieffenbachQ37075433
Argyrios ZiogasQ30831638
Shan Wang-GohrkerQ30831711
Katarzyna Jaworska-BieniekQ37075915
Caroline SeynaeveQ37342673
Thilo DörkQ37342847
Florence MenegauxQ37358234
Marina BermishevaQ37360473
Peter DevileeQ37361664
Paolo PeterlongoQ37361857
Taru A. MuranenQ37371838
Minouk J SchoemakerQ37371896
Jingmei LiQ37371985
Marjanka K SchmidtQ37372106
Paolo RadiceQ37372139
Sara LindstroemQ77022171
Peter KraftQ77526208
Julia A. KnightQ78316584
Nick OrrQ78318000
Janet E. OlsonQ78318964
Christa StegmaierQ78334823
Carmel ApicellaQ84487301
Thomas BrüningQ84487350
Daniel R TessierQ86844345
Lothar HaeberleQ87976657
Daniel Limones-HerreroQ88173248
Frederik MarméQ88268377
Rulla M TamimiQ88477882
Amy Trentham-DietzQ88960210
Polly A NewcombQ89454622
William D TapQ90147379
Hans ChristiansenQ90373551
Vernon PankratzQ90603683
Peter HillemannsQ91084009
Jonathan P TyrerQ91084019
Hans WildiersQ91254016
Miriam V DwekQ92181262
Michael J KerinQ92359739
Christian SutterQ92480964
Susan L SlagerQ92530010
Mark P GoldbergQ96133446
Anthony RenwickQ96759345
Valeria PensottiQ97414997
Rosemary L BalleineQ98177088
Jaana M HartikainenQ56204836
Emiel RutgersQ110419368
Peter SchürmannQ113623412
Natalia AntonenkovaQ113623741
Manjeet K BollaQ114270702
Sheila SealQ114292602
Alice J SigurdsonQ114292605
Michele M DoodyQ114292606
Ans M W van den OuwelandQ114292607
Amanda Ewart TolandQ38300105
Grethe Grenaker AlnæsQ40177166
Tjoung-Won Park-SimonQ42170981
Alice S. WhittemoreQ42423380
Sandra Deming-HalversonQ42438267
France LabrècheQ42439536
Keith HumphreysQ43401810
Børge G. NordestgaardQ43530123
Isabel dos Santos SilvaQ46514218
Mark RobsonQ51026477
Shahana AhmedQ54208457
Melissa C. SoutheyQ55446228
Carl BlomqvistQ73625505
Annegien BroeksQ73632596
Gord GlendonQ73633107
Brian E. HendersonQ73660621
Henrik FlygerQ74012148
Malcolm W. R. ReedQ74013381
Nichola JohnsonQ74014116
Maartje J. HooningQ74014444
Natalia V. BogdanovaQ74171899
Elinor J. SawyerQ74173254
Celine M. VachonQ74173260
P2093author name stringQin Wang
Diana Torres
Judith Brown
Rodney Scott
Kathleen M Egan
Christof Sohn
Rongxi Yang
Caroline Baynes
Catherine S Healey
Daniel Vincent
Francois Bacot
M Pilar Zamora
M Rosario Alonso
Marie Sanchez
Martine Dumont
Nuria Álvarez
Song Yao
Chantal Van Ongeval
Linda Titus
Jane Carpenter
Katherine Annie Perkins
P2860cites workPrevention of breast cancer in the context of a national breast screening programmeQ57266562
Large-scale genotyping identifies 41 new loci associated with breast cancer riskQ29416989
Genome-wide association studies identify four ER negative-specific breast cancer risk lociQ24622610
Genome-wide association study identifies novel breast cancer susceptibility lociQ24645441
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant dataQ30620889
Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the diseaseQ30665466
Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women StudyQ33935171
Performance of common genetic variants in breast-cancer risk modelsQ34064069
Assessment of clinical validity of a breast cancer risk model combining genetic and clinical informationQ34267477
The benefits and harms of breast cancer screening: an independent reviewQ34309421
Effect of three decades of screening mammography on breast-cancer incidenceQ34313044
Combined associations of genetic and environmental risk factors: implications for prevention of breast cancerQ34736112
Polygenic susceptibility to prostate and breast cancer: implications for personalised screeningQ34977428
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association ConsortiumQ35119701
Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screeningQ35136955
The genetic epidemiology of breast cancer genesQ35959353
Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurementQ36393193
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factorsQ36720821
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancersQ36742577
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancerQ36897003
Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor statusQ37223335
Polygenes, risk prediction, and targeted prevention of breast cancerQ81523323
A role for common genomic variants in the assessment of familial breast cancerQ85312916
Public health implications from COGS and potential for risk stratification and screeningQ86499074
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortiumQ37619303
A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impactQ37632049
Genetic susceptibility to breast cancerQ41130542
Incidence of Breast Cancer and Its Subtypes in Relation to Individual and Multiple Low-Penetrance Genetic Susceptibility LociQ42955271
Breast cancer screening: time to target women at riskQ43128186
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectbreast cancerQ128581
P577publication date2015-04-08
P1433published inJournal of the National Cancer InstituteQ400279
P1476titlePrediction of breast cancer risk based on profiling with common genetic variants
P478volume107

Reverse relations

cites work (P2860)
Q9033986312 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population
Q38844517A Review of Whole-Exome Sequencing Efforts Toward Hereditary Breast Cancer Susceptibility Gene Discovery
Q37697979A clinical model for identifying the short-term risk of breast cancer
Q33845912A monograph proposing the use of canine mammary tumours as a model for the study of hereditary breast cancer susceptibility genes in humans
Q38958555A polygenic risk score for breast cancer risk in a Taiwanese population.
Q46258028A qualitative study on Singaporean women's views towards breast cancer screening and Single Nucleotide Polymorphisms (SNPs) gene testing to guide personalised screening strategies
Q57748350Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study
Q38662947Adherence to Mediterranean Diet and Metabolic Syndrome in BRCA Mutation Carriers
Q89534097Adventures in the environment and genes
Q39437211Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers
Q58613780Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC)
Q33767039An alternative model for (breast) cancer predisposition
Q39551156An investigation of the association of genetic susceptibility risk with somatic mutation burden in breast cancer
Q56893420Assessing the Incremental Contribution of Common Genomic Variants to Melanoma Risk Prediction in Two Population-Based Studies
Q90051408Assessing thyroid cancer risk using polygenic risk scores
Q38776757Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study
Q57612089Association of Polygenic Risk Scores for Multiple Cancers in a Phenome-wide Study: Results from The Michigan Genomics Initiative
Q52576610Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.
Q60309353Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes
Q39500666Beyond Endometriosis Genome-Wide Association Study: From Genomics to Phenomics to the Patient
Q42363834Breast Cancer Risk Estimation and Personal Insurance: A Qualitative Study Presenting Perspectives from Canadian Patients and Decision Makers
Q39734134Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States
Q87909686Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening
Q36619329Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry
Q30238753Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.
Q40605693Breast cancer risk prediction using a clinical risk model and polygenic risk score
Q37410693Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab
Q52586080Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?
Q35834376Can the breast screening appointment be used to provide risk assessment and prevention advice?
Q91211233Cancer genetics, precision prevention and a call to action
Q92475989Chromatin interactome mapping at 139 independent breast cancer risk signals
Q92282006Cirrus: An Automated Mammography-Based Measure of Breast Cancer Risk Based on Textural Features
Q89746441Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field
Q59238197Clinical follow-up and breast and ovarian cancer screening of true BRCA1/2 noncarriers: a qualitative investigation
Q37364628Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies
Q64458461Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma
Q47703662Common Genetic Variation and Breast Cancer Risk - Past, present, and future
Q92528444Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification
Q38804228Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas
Q52584688Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group.
Q31064480Constructing Hypothetical Risk Data from the Area under the ROC Curve: Modelling Distributions of Polygenic Risk
Q38444625Cross-Phenotype Polygenic Risk Score Analysis of Persistent Post-Concussive Symptoms in U.S. Army Soldiers with Deployment-Acquired Traumatic Brain Injury
Q47298550Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants
Q30251440Developing and evaluating polygenic risk prediction models for stratified disease prevention
Q37138925Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial
Q57108215Elucidating the Underlying Functional Mechanisms of Breast Cancer Susceptibility Through Post-GWAS Analyses
Q64058041Epidemiological characteristics of and risk factors for breast cancer in the world
Q38368693Epidemiology of Esophageal Squamous Cell Carcinoma.
Q92103705Epithelial ovarian cancer risk: A review of the current genetic landscape
Q98184153European polygenic risk score for prediction of breast cancer shows similar performance in Asian women
Q33614244Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers
Q57172770Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study
Q55040393Evaluation of three polygenic risk score models for the prediction of breast cancer risk in Singapore Chinese.
Q38739215Extensions of the Rosner-Colditz breast cancer prediction model to include older women and type-specific predicted risk.
Q48029327Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families
Q50051819Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort.
Q45963434Feasibility of structured endurance training and Mediterranean diet in BRCA1 and BRCA2 mutation carriers - an interventional randomized controlled multicenter trial (LIBRE-1).
Q90374343Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic
Q64087937Functional Analysis of Promoter Variants in Genes Involved in Sex Steroid Action, DNA Repair and Cell Cycle Control
Q99633744Gene panel screening for insight towards breast cancer susceptibility in different ethnicities
Q26772236Gene-environment interaction and risk of breast cancer
Q42868000Genetic Determinants of Breast Cancer Risk in Childhood Cancer Survivors
Q47945968Genetic Test, Risk Prediction, and Counseling.
Q64080586Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer
Q36316307Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score
Q50057756Genetic determinants of sporadic breast cancer in Sri Lankan women.
Q37739048Genetic modifiers of CHEK2*1100delC-associated breast cancer risk
Q91235528Genetic risk scores for major psychiatric disorders and the risk of postpartum psychiatric disorders
Q62583135Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma
Q47207156Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry
Q33609333Genetics for population and public health
Q92471097Geographic Variation and Bias in the Polygenic Scores of Complex Diseases and Traits in Finland
Q59756250Germline Variation and Breast Cancer Incidence: A Gene-Based Association Study and Whole-Genome Prediction of Early-Onset Breast Cancer
Q91525724Germline variants in cancer genes in high-risk non-BRCA patients from Puerto Rico
Q38608277High-Definition Medicine
Q64934338High-risk women's risk perception after receiving personalized polygenic breast cancer risk information.
Q37670725Hormone receptor status and survival of medullary breast cancer patients. A Turkish cohort.
Q46103372Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
Q90460444Illustrating Cancer Risk: Patient Risk Communication Preferences and Interest regarding a Novel BRCA1/2 Genetic Risk Modifier Test
Q48717652Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials.
Q40310422Implications of polygenic risk for personalised colorectal cancer screening
Q92711915Incidence of breast cancer attributable to breast density, modifiable and non-modifiable breast cancer risk factors in Singapore
Q92281992Inclusion of Plasma Prolactin Levels in Current Risk Prediction Models of Premenopausal and Postmenopausal Breast Cancer
Q37378034Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model
Q53400538Increased COX-2 expression in epithelial and stromal cells of high mammographic density tissues and in a xenograft model of mammographic density.
Q48181769Inherited factors contribute to an inverse association between preeclampsia and breast cancer
Q37360550Integrating precision cancer medicine into healthcare-policy, practice, and research challenges
Q89866318Interactions between a Polygenic Risk Score and Non-genetic Risk Factors in Young-Onset Breast Cancer
Q64279327Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk
Q47190168Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium
Q33829049Joint modeling of genetically correlated diseases and functional annotations increases accuracy of polygenic risk prediction
Q40089754Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones.
Q96302976Key steps for effective breast cancer prevention
Q33825680Leveraging functional annotations in genetic risk prediction for human complex diseases
Q37513545Lifestyle intervention in BRCA1/2 mutation carriers: study protocol for a prospective, randomized, controlled clinical feasibility trial (LIBRE-1 study).
Q43843244Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction
Q54730200Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening.
Q58769239Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls
Q47822347Making Sense of SNPs: Women's Understanding and Experiences of Receiving a Personalized Profile of Their Breast Cancer Risks.
Q36298470Mammographic density defined by higher than conventional brightness threshold better predicts breast cancer risk for full-field digital mammograms.
Q41010078Mammographic density defined by higher than conventional brightness thresholds better predicts breast cancer risk
Q37463923Modeling the prevention of colorectal cancer from the combined impact of host and behavioral risk factors.
Q58556516Multi-gene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families
Q24658557Multigene testing of moderate-risk genes: be mindful of the missense
Q49553408Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations.
Q93059865Novel mutations in actionable breast cancer genes by targeted sequencing in an ethnically homogenous cohort
Q36591738Odds per adjusted standard deviation: comparing strengths of associations for risk factors measured on different scales and across diseases and populations
Q91892103PRSice-2: Polygenic Risk Score software for biobank-scale data
Q36574725Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity
Q57453316Personalised medicine and population health: breast and ovarian cancer
Q92323619Perspective: The Clinical Use of Polygenic Risk Scores: Race, Ethnicity, and Health Disparities
Q58113261Polygenic Determinants for Subsequent Breast Cancer Risk in Survivors of Childhood Cancer: The St Jude Lifetime Cohort Study (SJLIFE)
Q26750522Polygenic Epidemiology
Q62583133Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Q88666837Polygenic Risk Scores: What Are They Good For?
Q92638472Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification
Q37131918Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families
Q57172887Polygenic risk score of shorter telomere length and risk of depression and anxiety in women
Q97524107Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants
Q92966277Polygenic risk-stratified screening for cancer: Responsibilization in public health genomics
Q96163551Practical implementation of frailty models in Mendelian risk prediction
Q36356727Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores
Q37487782Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry
Q47409320Predictive accuracy of combined genetic and environmental risk scores
Q40474074Previous GWAS hits in relation to young-onset breast cancer.
Q36229139Primary care providers' cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agenda
Q47574889Prospects for using risk scores in polygenic medicine
Q33916899Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study
Q31046674Reclassification of genetic-based risk predictions as GWAS data accumulate
Q37524981Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies
Q37101570Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk
Q92710828Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patients
Q36545643Risk prediction for sporadic Alzheimer's disease using genetic risk score in the Han Chinese population
Q54950358Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data.
Q58696903SNP interactions of PGC with its neighbor lncRNAs enhance the susceptibility to gastric cancer/atrophic gastritis and influence the expression of involved molecules
Q36322904SNPs and breast cancer risk prediction for African American and Hispanic women
Q97883645SNPs in lncRNA Regions and Breast Cancer Risk
Q55013059Saliva samples as a source of DNA for high throughput genotyping: an acceptable and sufficient means in improvement of risk estimation throughout mammographic diagnostics.
Q52648599Simulating the Impact of Risk-Based Screening and Treatment on Breast Cancer Outcomes with MISCAN-Fadia.
Q92276452Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis
Q92187296Somatic variants of potential clinical significance in the tumors of BRCA phenocopies
Q33734235Structure-Leveraged Methods in Breast Cancer Risk Prediction
Q92993050Systematic evaluation of cancer-specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts
Q36545434Systematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancer
Q37444608Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes
Q38842051Testing for Gene-Environment Interactions Using a Prospective Family Cohort Design: Body Mass Index in Early and Later Adulthood and Risk of Breast Cancer.
Q47161591The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol.
Q28552519The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control Study
Q92282029The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic Approaches
Q41701590The WISDOM Study: breaking the deadlock in the breast cancer screening debate
Q28074414The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance
Q88778863The personal and clinical utility of polygenic risk scores
Q49356370The use of panel testing in familial breast and ovarian cancer.
Q64240122Towards a more precise and individualized assessment of breast cancer risk
Q47397232Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach
Q42366133Trans-ethnic predicted expression genome-wide association analysis identifies a gene for estrogen receptor-negative breast cancer
Q89961489Transcriptome-wide association study of breast cancer risk by estrogen-receptor status
Q52632715Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention.
Q59335358Update Breast Cancer 2018 (Part 3) – Genomics, Individualized Medicine and Immune Therapies – in the Middle of a New Era: Prevention and Treatment Strategies for Early Breast Cancer
Q64102998Update Breast Cancer 2019 Part 1 - Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer
Q64273108Update Breast Cancer 2019 Part 3 – Current Developments in Early Breast Cancer: Review and Critical Assessment by an International Expert Panel
Q90092211Update Breast Cancer 2020 Part 1 - Early Breast Cancer: Consolidation of Knowledge About Known Therapies
Q36255311Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention
Q57040851Validation of a genetic risk score for Arkansas women of color
Q97093695Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort
Q28917124Winner's Curse Correction and Variable Thresholding Improve Performance of Polygenic Risk Modeling Based on Genome-Wide Association Study Summary-Level Data
Q36678510iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management

Search more.